InspireMD, Inc.
NSPR
$0.73
-$0.05-5.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 54.38% | 28.11% | 14.04% | 7.60% | 8.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.38% | 28.11% | 14.04% | 7.60% | 8.49% |
| Cost of Revenue | 41.35% | 15.03% | 10.65% | 11.54% | 16.21% |
| Gross Profit | 102.12% | 75.90% | 25.68% | -4.98% | -12.75% |
| SG&A Expenses | 64.54% | 74.32% | 72.29% | 52.81% | 39.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.29% | 44.63% | 48.72% | 46.56% | 45.42% |
| Operating Income | -38.84% | -48.09% | -56.62% | -56.00% | -55.32% |
| Income Before Tax | -42.03% | -52.52% | -63.79% | -62.31% | -59.46% |
| Income Tax Expenses | 6.78% | 6.78% | -9.23% | -9.23% | -9.23% |
| Earnings from Continuing Operations | -41.98% | -52.43% | -63.62% | -62.13% | -59.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.98% | -52.43% | -63.62% | -62.13% | -59.26% |
| EBIT | -38.84% | -48.09% | -56.62% | -56.00% | -55.32% |
| EBITDA | -38.57% | -47.90% | -56.64% | -56.17% | -55.62% |
| EPS Basic | 7.24% | -2.63% | -12.29% | -12.57% | -4.61% |
| Normalized Basic EPS | 7.18% | -2.72% | -12.43% | -12.72% | -4.73% |
| EPS Diluted | 7.24% | -2.63% | -12.29% | -12.57% | -4.61% |
| Normalized Diluted EPS | 7.18% | -2.72% | -12.43% | -12.72% | -4.73% |
| Average Basic Shares Outstanding | 58.71% | 53.44% | 46.83% | 43.94% | 48.97% |
| Average Diluted Shares Outstanding | 58.71% | 53.44% | 46.83% | 43.94% | 48.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |